Previous 10 | Next 10 |
2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...
2024-05-10 07:17:32 ET More on Moderna Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Moderna Investors Should Beware Patent-Dispute Fallout Moderna to seek parity for RSV shot as rivals lead...
U.S. FDA has informed Moderna that due to administrative constraints, the agency will not complete its review of mRNA-1345 by the PDUFA date of May 12, 2024 Agency has indicated it expects to complete the review by end of May CAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (N...
2024-05-09 13:22:28 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Catalent, Novo Nordisk receive FTC request for mo...
2024-05-09 09:05:00 ET Five years ago, pharmaceutical company Moderna (NASDAQ: MRNA) was mostly unknown. It was developing vaccines that induce human immune cells to more effectively fight disease. But the science of DNA-based drugs was on the experimental fringe of the biopharma la...
2024-05-08 11:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-08 10:47:03 ET Geo Group, Inc. (GEO) GEO is trading DOWN for the last 4 days, and it at trading at $13.61 with volume of 5,634,472 and a one day change of $-0.83 (-5.72%). Geo Group, Inc. has a 52-week low of 6.94 and a 52-week high of $16.31. The business's 50-day moving av...
2024-05-08 08:30:00 ET Summary Pfizer Inc.'s COVID vaccine revenue plunged to $354M in Q1, indicating a dramatic reset. It should help Pfizer potentially outperform moving ahead as it laps easier comps. Pfizer is a fundamentally strong stock with a dividend yield of almost 6%....
PALM BEACH, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - There is much activity in finding better ways in mitigating muscle loss for the cancer patients… many clinical studies are looking for elite performance nutritional supplements to mitigate the m...
2024-05-08 07:06:13 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca invests $140M in Cellectis, raising stake to 44% ...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its second quarter 2024 financial results, and provide a corporate update. A live webcast of the c...
CAMBRIDGE, MA AND OSAKA, JAPAN / ACCESSWIRE / July 8, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Mitsubishi Tanabe Pharma Corporation today announced that the companies have entered into a joint agreement regarding the co-promotion of Moderna's mRNA respiratory vaccine portfolio in Japan, including ...
CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...